{'fraction_non_alphanumeric': 0.0488997555012225, 'fraction_numerical': 0.013447432762836185, 'mean_word_length': 5.604838709677419, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Recent progress in cancer therapeutics.

From November 11 to 13, 2008, the Chulabhorn Research Institute welcomed approximately 450 scientists working in experimental and clinical cancer research at the Chulabhorn Convention Center, Bangkok, Thailand. Prof. Dr. HRH Princess Chulabhorn, Conference and Scientific Chairperson, together with the cochairpersons Dr. Enrico Mihich (USA) and Dr. Kurt S. Zanker (Germany) and with the Secretary General, Dr. Khunying Mathuros Ruchirawat, designed a scientific program at the cutting edge of “Recent Progress in Cancer Therapeutics.” The meeting was under the joint sponsorship of the American Association for Cancer Research (USA), the Chulabhorn Research Institute (Thailand), the Fritz-Bender-Foundation (Germany), and Mrs. Sybille Bartels-Hetzler (KPMG Hamburg, Germany).